EP1824756B1 - Primärverpackungseinheit für flächenförmige darreichungsformen - Google Patents
Primärverpackungseinheit für flächenförmige darreichungsformen Download PDFInfo
- Publication number
- EP1824756B1 EP1824756B1 EP05809149A EP05809149A EP1824756B1 EP 1824756 B1 EP1824756 B1 EP 1824756B1 EP 05809149 A EP05809149 A EP 05809149A EP 05809149 A EP05809149 A EP 05809149A EP 1824756 B1 EP1824756 B1 EP 1824756B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- packaging unit
- unit according
- primary packaging
- packaging
- primary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Not-in-force
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
Definitions
- the present invention relates to a primary packaging unit for sheet-like administration forms with active ingredients, each having a section of packaging material and each having one or more sections of Packstoffober- and -unterbahn, the dosage forms and the packaging material upper and Unterbahn on mutually opposite sides of the packaging material are dimensioned and wherein the packaging material center line is dimensioned according to a card in which the packaging material web is rigid and represents the basis of the card, the packaging material web is a thin film with water vapor barrier properties, the packaging material web is a thin film with water vapor barrier properties and multiple dose units together with the individual components Map by sealing or gluing on an in-line packaging machine are connected to one another so that the sheet-like dosage forms individually ve remain packed even if one of the dosage forms is removed.
- Flat administration forms in the context of this application are, for example, topically applied cosmetic, medicinal or active ingredient-containing patches such as wart plasters, insect stick plasters or nail plasters, mucoadhesive gingiva patches or oral oral films.
- This dosage form is particularly suitable for travel or for activities or situations in which a quick and convenient intake of the medication without liquid is desired.
- sheet-like dosage form in the context of this application and highlighting is that these forms of delivery especially on the road, for example, when traveling, to provide quick help. Ideally, these forms of administration can therefore be comfortably and inconspicuously carried by the user as well as always at hand, for example in the wallet, shirt or trouser pocket.
- the dosage forms can be drugs, individual packaging of each single dose must be realized.
- the primary packaging unit proposed there consists only of one section each of a packaging material upper and lower web, whereby the available area of the primary packaging unit is used only on one side.
- twice the area is required for the primary packaging unit.
- sheet-like administration forms of a particularly preferred size of 4-7 cm 2 if one still wants to carry a reasonable number of individual doses, this leads to such a large packaging unit that it can no longer be comfortably carried along the body without bending it. which, however, may compromise the integrity of the package and thus the dosage form.
- a primary packaging unit for sheet-like dosage forms with active ingredients is already known, in which a packaging material web is rigid and designed as the basis for the packaging unit.
- Packaging material webs for fixing and enclosing the dosage forms are formed like a film and provided with water vapor barrier properties.
- the film-shaped webs are connected to the packaging material middle web to form a unit.
- a primary packaging unit for sheet-like dosage forms ( Fig.2 . 4 ), with a section of a rigid packaging material middle web ( Fig.2, 1 ) and each with one or more sections of a flexible packaging upper and lower web ( Fig.2, 2 ), which is characterized in that the rigid packaging material middle web, on which a variable number of sheet-like administration forms can be applied on both sides ( 2b ), are connected on one side with one or more sections of flexible packaging material web and on the opposite side with one or more sections of flexible packaging material web by sealing or gluing together so that a solid but flexible card of maximum 1mm thickness is obtained, in which the sheet-like dosage forms are individually packaged and remain, even if one of the several dosage forms is removed without the card has a perforation between the individually packaged dosage forms.
- a rapid card in any size is possible, but particularly preferred is an embodiment that corresponds in size to a credit card, as in Fig.1 and 2 shown.
- This standardized measure makes it possible to carry the Rapidcard conveniently in the breast pocket, a shirt, the back pocket of a pair of trousers or in the purse.
- a variant is particularly preferred in which 2-10 area-shaped dosage forms of 2-10 cm 2 area, more preferably 3 area-shaped dosage forms of 4-7 cm 2 area are packed on each side of the card.
- a carrier film for example, from PE, PP, PVC, PETG, PETGAG, COC or multilayer laminates such as PE / paper / PE, PE / PVC / PE, etc., 6 rectangular, surface-shaped dosage forms of 6 cm 2 area are applied ,
- three dosage forms are applied to both the front and on the back of the carrier film so that they do not touch each other and a sufficient distance between them to each dosage form individually by sealing or gluing one or more sections of a flexible packaging material or to completely enclose the underground and thus protect it against external influences (cf. 2b ).
- the packaging material upper or lower web is a sheet-like, thin material of a maximum thickness of 0.2 mm, which is a barrier to atmospheric moisture and atmospheric oxygen ( Fig.2, 2 and Fig. 4 , hereinafter referred to as protective film).
- protective film After sealing or gluing, this material must have the property of being peelable, that is, after one or more sections of this protective film have been sealed or glued to the rigid support film, it must be possible to use it at a later time with little Remove the force again from the carrier film to remove the appropriate dosage form.
- film-like materials with different barrier properties come into question, depending on the properties of the dosage forms to be packaged.
- a transparent film with barrier properties to humidity such as PE / PCTFE / PE can be used if the product is to be visible and there is no photosensitivity.
- the PCTFE must have a minimum thickness of 50 ⁇ m.
- a film may be used which is colored or coated or contains an aluminum layer, whereby In addition to the sunscreen protection against moisture and atmospheric oxygen is given.
- the machine parameters during the sealing or gluing process as well as the width of the sealing seam or adhesive surface obtained in the corresponding method are chosen such that the product is efficiently protected against external factors influencing stability for the period of the determined durability, and nevertheless at a later point in time easy opening of the sealing seam or adhesive surface for removal is possible.
- the one or more sections of the protective film are - should this not already be given by the nature of the sealing or gluing process - further in such a way that it is possible to open the seal or adhesive surface only an individual dosage form and remove it without opening or damaging the protective packaging of a neighboring dosage form. This can be achieved, for example, by virtue of the protective film having an incision at the sealing seam or adhesive surface between the individual dosage forms ( Fig.2 . 5 ).
- the protective film can be designed so that it has a pull tab for easier opening for each individual dosage form.
- a pull tab is a part of the protective film, which is in direct contact with the individually packaged dosage form, but is not connected by sealing, gluing or other measures with the carrier film, but rests loosely on the carrier film.
- the sealing seam or adhesive surface of the corresponding area of the card can be opened and the planar dosage form removed.
- a predetermined breaking point can also be provided here.
- Both the carrier film and the protective films can be printed with information if required ( Fig. 1 ).
Landscapes
- Chemical & Material Sciences (AREA)
- Composite Materials (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Packages (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Containers And Plastic Fillers For Packaging (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004056576A DE102004056576A1 (de) | 2004-11-23 | 2004-11-23 | Rapidcard |
PCT/DE2005/002006 WO2006056161A1 (de) | 2004-11-23 | 2005-11-09 | Primärverpackungseinheit für flächenförmige darreichungsformen |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1824756A1 EP1824756A1 (de) | 2007-08-29 |
EP1824756B1 true EP1824756B1 (de) | 2010-03-17 |
Family
ID=35655531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05809149A Not-in-force EP1824756B1 (de) | 2004-11-23 | 2005-11-09 | Primärverpackungseinheit für flächenförmige darreichungsformen |
Country Status (7)
Country | Link |
---|---|
US (1) | US20080116104A1 (es) |
EP (1) | EP1824756B1 (es) |
AT (1) | ATE461128T1 (es) |
CA (1) | CA2595110A1 (es) |
DE (2) | DE102004056576A1 (es) |
ES (1) | ES2342546T3 (es) |
WO (1) | WO2006056161A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2248519T3 (pl) | 2006-10-02 | 2018-04-30 | Apr Applied Pharma Research S.A. | Niemukoadhezyjne postaci dawkowania w postaci filmu |
USD837066S1 (en) | 2017-09-14 | 2019-01-01 | Split Nutrition, LLC | Multi-compartment food package |
USD859178S1 (en) | 2017-09-14 | 2019-09-10 | Split Nutrition, LLC | Multi-compartment food package |
USD875548S1 (en) | 2017-09-14 | 2020-02-18 | Split Nutrition, LLC | Multi-compartment food package |
USD866344S1 (en) | 2017-09-14 | 2019-11-12 | Good Seed Snack Company, LLC | Multi-compartment food package |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2779465A (en) * | 1954-04-13 | 1957-01-29 | Anderson Orval William | Composite disposable pad |
US3540579A (en) * | 1968-03-27 | 1970-11-17 | Hellstrom Harold R | Individualized dispensing packages |
US3521805A (en) * | 1968-09-27 | 1970-07-28 | Anderson Bros Mfg Co | Dispensing packet |
US3603453A (en) * | 1969-06-09 | 1971-09-07 | Parke Davis & Co | Pharmacal package construction |
US3861529A (en) * | 1970-10-16 | 1975-01-21 | Picker Corp | Package and method of making |
DE2532958A1 (de) * | 1974-08-22 | 1976-03-04 | Schreiber Cheese Co L D | Verpackung und verfahren zu deren herstellung |
US3966045A (en) * | 1975-05-12 | 1976-06-29 | W. R. Grace & Co. | Skin package |
US4911304A (en) * | 1989-03-20 | 1990-03-27 | Merck & Co., Inc. | Sandwich blister package for tablets and similar articles |
DK294090A (da) * | 1990-12-11 | 1992-06-12 | Kokkedyd Aps | Foedevareemballage |
US5511689A (en) * | 1993-12-28 | 1996-04-30 | Frank; Richard D. | Dispensing device for adhesive-backed articles |
DE19715550C1 (de) * | 1997-04-15 | 1998-05-20 | Becker Industrievertretungen G | Verfahren zum Skinverpacken von Packgut und Skinverpackung |
DE29823463U1 (de) * | 1998-01-10 | 1999-07-22 | LTS Lohmann Therapie-Systeme GmbH, 56567 Neuwied | Primärverpackungseinheit für film- oder oblatenartige Darreichungsformen |
US6319510B1 (en) * | 1999-04-20 | 2001-11-20 | Alayne Yates | Gum pad for delivery of medication to mucosal tissues |
WO2002013762A2 (en) * | 2000-08-10 | 2002-02-21 | Delsys Pharmaceutical Corporation | Improved solid pharmaceutical dosage formulation of hydrophobic drugs |
SE516478C2 (sv) * | 2001-04-25 | 2002-01-22 | Ragnar Winberg | Blisterförpackning |
US6726054B2 (en) * | 2002-03-29 | 2004-04-27 | Tapemark | Dispenser package arrangement and methods |
US6818269B2 (en) * | 2002-09-27 | 2004-11-16 | Dot Packaging Group, Inc. | Metallic board |
US6708826B1 (en) * | 2003-04-30 | 2004-03-23 | Warner-Lambert Company, Llc | Packaged supply of individual doses of a personal care product |
-
2004
- 2004-11-23 DE DE102004056576A patent/DE102004056576A1/de not_active Withdrawn
-
2005
- 2005-11-09 ES ES05809149T patent/ES2342546T3/es active Active
- 2005-11-09 CA CA002595110A patent/CA2595110A1/en not_active Abandoned
- 2005-11-09 AT AT05809149T patent/ATE461128T1/de not_active IP Right Cessation
- 2005-11-09 WO PCT/DE2005/002006 patent/WO2006056161A1/de active Application Filing
- 2005-11-09 EP EP05809149A patent/EP1824756B1/de not_active Not-in-force
- 2005-11-09 US US11/791,256 patent/US20080116104A1/en not_active Abandoned
- 2005-11-09 DE DE502005009254T patent/DE502005009254D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
EP1824756A1 (de) | 2007-08-29 |
US20080116104A1 (en) | 2008-05-22 |
DE102004056576A1 (de) | 2006-05-24 |
WO2006056161A1 (de) | 2006-06-01 |
CA2595110A1 (en) | 2006-06-01 |
ATE461128T1 (de) | 2010-04-15 |
ES2342546T3 (es) | 2010-07-08 |
DE502005009254D1 (de) | 2010-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1799579B1 (de) | Peelfähige, kindersichere verpackung für filmförmige arzneiformen | |
DE19853737C2 (de) | Verfahren zum Spenden von flächigen Gebilden | |
DE69518759T2 (de) | Verwandelbare, kindersichere blisterpackung | |
EP2059455B1 (de) | Verpackung für wirkstoffhaltige filme und verfahren für deren herstellung | |
EP1140650B1 (de) | Verpackung für flächenförmige gebilde/produkte | |
DE69506267T2 (de) | Blisterpackung mit trockenmittel | |
EP1824756B1 (de) | Primärverpackungseinheit für flächenförmige darreichungsformen | |
DE202004021140U1 (de) | Neue Arzneimittelverpackung | |
EP1161375B1 (de) | Sammelpackung zur entnahme von befüllten beuteln in vorgegebener reihenfolge | |
EP0705204B1 (de) | Beutelverpackung für flüssige arzneimittel | |
WO1999035051A1 (de) | Primärverpackungseinheit für film- oder oblatenartige darreichungsformen | |
DE102010028361A1 (de) | Wafertasche mit aufreißbarem Waferaufnahmefach | |
EP2874908B1 (de) | Verpackung für einzeldosierte wirkstoffhaltige filme und verfahren zur herstellung dieser verpackung | |
WO2007028507A1 (de) | Wafervial mit inerten zwischenlagen | |
DE10008165A1 (de) | Verpackung flächenförmiger Gegenstände mit verbesserter Aufreisseigenschaft | |
EP1594761B1 (de) | Primärverpackung als applikator | |
DE102010028351A1 (de) | Wafertasche | |
DE3931019C2 (es) | ||
EP2521114B1 (de) | Aufhängeetikett für einen Flüssigkeitsbeutel und Verfahren zum Anbringen eines Etiketts an einem mit Flüssigkeit gefüllten Beutel | |
DE19820999A1 (de) | Laminat zum Aufbringen auf einen Akzeptor | |
WO2002038138A2 (de) | Primärverpackung für transdermale therapeutische systeme oder medizinische pflaster | |
DE202006005907U1 (de) | Aufhänge- und Kennzeichnungsvorrichtung | |
DE29823463U1 (de) | Primärverpackungseinheit für film- oder oblatenartige Darreichungsformen | |
CH570907A5 (en) | Sensitive item sheet packing - has pull-off flexible sheet attached to rigid one forming pockets | |
EP2999443B1 (de) | Pflaster mit abziehhilfe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070223 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20080729 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: LABTEC GMBH |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 502005009254 Country of ref document: DE Date of ref document: 20100429 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2342546 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20100317 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 |
|
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20100317 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100618 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100717 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100617 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100719 Ref country code: IE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 |
|
26N | No opposition filed |
Effective date: 20101220 |
|
BERE | Be: lapsed |
Owner name: LABTEC G.M.B.H. Effective date: 20101130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101130 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101130 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101130 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 461128 Country of ref document: AT Kind code of ref document: T Effective date: 20101109 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101109 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100918 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101109 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100317 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 502005009254 Country of ref document: DE Representative=s name: KOENIG SZYNKA TILMANN VON RENESSE PATENTANWAEL, DE Ref country code: DE Ref legal event code: R081 Ref document number: 502005009254 Country of ref document: DE Owner name: APR APPLIED PHARMA RESEARCH S.A., CH Free format text: FORMER OWNER: LABTEC GMBH, 40764 LANGENFELD, DE |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP Owner name: APR APPLIED PHARMA RESEARCH S.A., CH Effective date: 20151027 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20151105 AND 20151111 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: CD Owner name: APR APPLIED PHARMA RESEARCH S.A., CH Effective date: 20151027 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: PC2A Owner name: APR APPLIED PHARMA RESEARCH S.A. Effective date: 20180110 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20181128 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20181127 Year of fee payment: 14 Ref country code: IT Payment date: 20181123 Year of fee payment: 14 Ref country code: GB Payment date: 20181127 Year of fee payment: 14 Ref country code: ES Payment date: 20181203 Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 502005009254 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20191109 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200603 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191130 Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191109 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191109 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20210414 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191110 |